Widening MedTech’s Wars Against Migraines, Cardiac Fibrillation

In this episode of DeviceTalks Weekly, Host Kayleen Brown talks with Joanna Nathan, CEO and Co-Founder of Prana Surgical, about why catching lung nodules earlier requires a right-sized approach to surgical intervention. Nathan explains Prana’s goal of bringing a lumpectomy approach to lung surgery and how the company is developing its technology to localize and remove nodules while preserving surrounding healthy lung tissue. She distinguishes its initial focus on supporting tissue diagnosis from its longer-term vision of potentially treating lung cancer. Nathan also shares lessons from Prana’s first-in-human experience in Australia, including how observing clinicians using the device helped identify design and workflow improvements. Along the way, she discusses her path from bioengineering to entrepreneurship and how lean medtech teams can use AI while maintaining human oversight. In the FOMO interview, Andy Hansen, Global Director of Engineering at ATL Medical, discusses the future of pulsed field ablation and intravascular lithotripsy. We’ll open the episode with this week’s Newsmakers, covering CMR Surgical’s plans following Stryker’s investment, Intuitive’s U.S. procedure growth and quarterly results, Johnson & Johnson’s timeline for its orthopedics spinoff, Abbott’s planned Nutrition business spinoff, and Medtronic’s appointment of a corporate president. Special thanks to ATL Medical for sponsoring this episode of DeviceTalks Weekly. To learn more about how ATL Medical works with medical device companies, visit: ATLMedical.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Kayleen Brown welcomes back Rocco De Bernardis, Global President for Soft Tissue Robotic Surgery at Johnson & Johnson, to discuss the company’s OTTAVA™ Robotic Surgical System. De Bernardis explains why OTTAVA’s four robotic arms are integrated into the operating table and how the system’s smaller footprint could give surgical teams more room to work while helping hospitals bring robotic surgery to additional operating rooms. He also shares what Johnson & Johnson learned from OTTAVA’s clinical trial, including how the system performed in different operating-room environments and what the company’s FDA authorization means as it prepares for a commercial rollout with selected U.S. customers. The conversation also explores the technology behind OTTAVA, including its automated setup and docking, surgical instrumentation, and Polyphonic™, an open digital ecosystem designed to connect data from devices and systems across the operating room. De Bernardis discusses how these technologies could improve workflow, support surgical teams and create a foundation for the future of robotic surgery. Catch the 2023 interview with De Bernardis here: https://www.devicetalks.com/hear-why-j-a-vc-discusses-the-impact-of-glp-1-drugs/ Special thanks to this episode's sponsor, Harmonic Drive. To learn more about how Harmonic Drive works with medical device companies, visit harmonicdrive.net. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Better MedTech requires more than one perspective. In this episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown talks with Deanna Harshbarger, CEO of Cala Health, about designing for the whole picture, from patients’ everyday needs to the people, evidence, and business decisions that bring a technology to market. A chemical engineer turned business leader, Harshbarger shares lessons from her career at Johnson & Johnson, Boston Scientific, and Medtronic, including helping build Boston Scientific’s deep brain stimulation franchise and gaining experience with connected devices and direct-to-patient care at Medtronic. Now leading Cala Health, Harshbarger explains how those experiences inform the company’s noninvasive, wrist-worn therapy for action hand tremor in people with essential tremor and Parkinson’s disease. She discusses why clinical effectiveness and usability must go hand in hand, how regulation and reimbursement shape access, and why no single person holds the answer to building a product that works for patients and can scale sustainably. That philosophy also shapes her leadership: removing hurdles, welcoming different perspectives, and ensuring every person knows their voice matters. Kayleen also welcomes Yvonne Bokelman, Executive Director of MedtechWOMEN, for an in-studio conversation about highlights from MedtechVISION 2026, the organization’s growing mentorship and community programs, and why diverse perspectives are essential to better medical device development. Thank you to MedtechWOMEN for sponsoring this episode of the Women in MedTech podcast! To learn more about the organization, please visit: https://medtechwomen.org/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

The strongest MedTech innovation doesn't begin with technology in search of an application. It begins with a problem that matters enough to solve. In this episode of the Women in MedTech podcast, Host Kayleen Brown talks with Melaine DiLuzio, Vice President of U.S. Sales for Enabling Technologies within Medtronic’s Cranial & Spinal Technologies (CST) unit, about purposeful innovation—and the responsibility to connect every technology investment to a meaningful clinical need. Melaine shares how more than two decades in MedTech sales, including her progression from associate sales representative to executive leadership, have shaped her approach to purpose, preparation, and building teams that can lead through change. Melaine also unpacks how the CST division approaches enabling technologies: the connected tools for surgical planning, imaging, navigation, robotics, and execution that support cranial and spine procedures. She discusses the importance of designing technology around the realities of clinical workflow, adoption, and long-term utility—and why the most vital question innovators can ask remains: What problem are we solving with this technology? Kayleen also welcomes Caryn Mills, Medical Device Sales Director at HID Global, about how Radio-Frequency Identification (RFID) can support purposeful innovation throughout the medical device lifecycle. Caryn explains how RFID helps OEMs address challenges involving authentication, calibration, traceability, lifecycle management, workflow, and patient safety—and why teams should consider those needs early in the design process. Join us October 22nd and in December to learn more about RFID in two upcoming MDO webinars. Register for free here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415899/medical-design-outsourcing Thank you to HID Global for supporting this episode of the DeviceTalks Women in MedTech podcast. To learn more about how HID Global works with medical device companies, visit: https://www.hidglobal.com/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office. Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ technology for moving ear tube procedures out of the OR and into the physician’s office without general anesthesia. He explains how Preceptis is working with ENTs, pediatricians and parents to drive adoption and why changing even a five-minute procedure requires more than selling a medical device. For more information, visit https://www.hummingbirdeartubes.com We’ll open the episode with Newmarker’s Newsmakers featuring Mindray, Boston Scientific, Medtronic and Johnson & Johnson MedTech. This episode is sponsored by DeviceTalks Tuesdays Connected Health Series. Register at DeviceTalks.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe